首页> 美国卫生研究院文献>British Heart Journal >Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
【2h】

Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.

机译:梗死后心力衰竭对盐酸多巴胺的血流动力学反应:持续输注后缺乏耐受性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dopexamine is a new vasodilator with a combination of dopamine receptor and beta 2 adrenoreceptor agonist properties. Its haemodynamic effects were assessed after dose titration and during infusion for up to 24 hours in 15 patients with heart failure after acute myocardial infarction. At the initial titration a dose of 1 micrograms/kg/min produced a 25% decrease in the systemic vascular resistance index and a 32% increase in cardiac index. Stroke volume index and heart rate increased by 23% and 9% respectively. Left ventricular filling pressures and mean blood pressures were not affected. The short term effects were well sustained during the long term infusion and tolerance did not develop. Administration of dopexamine to patients with heart failure after acute myocardial infarction augments cardiac performance at rest.
机译:多巴胺是一种具有多巴胺受体和β2肾上腺素受体激动剂特性的新型血管扩张药。在15例急性心肌梗死后心力衰竭患者中,在剂量滴定后和输注长达24小时期间评估了其血流动力学效应。初始滴定时,剂量为1微克/千克/分钟可使全身血管阻力指数降低25%,心脏指数提高32%。中风量指数和心率分别增加23%和9%。左心室充盈压和平均血压不受影响。在长期输注期间,短期效果良好,并且未产生耐受性。在急性心肌梗塞后向心力衰竭患者服用多巴沙明可增强静息状态下的心脏功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号